Skip to main content
. 2015 Jul 27;38(10):1913–1920. doi: 10.2337/dc15-0783

Table 2.

Crude and adjusted HRs for incident fracture

A. All fracture sites
Person-years (n1) Crude HR (95% CI) Adjusted HR2 (95% CI) Person-years (n1) Crude HR (95% CI) Adjusted HR2 (95% CI)
Age-group Males Females
0–19 years 112,460 (30,623) 1.14 (1.01–1.29)4 1.14 (1.01–1.29)4 98,851 (26,525) 1.35 (1.12–1.63)5 1.35 (1.12–1.62)5
20–29 years 132,639 (34,860) 1.42 (1.24–1.63)4 1.40 (1.22–1.60)4 113,175 (32,587) 1.76 (1.43–2.17)4 1.72 (1.39–2.12)4
30–39 years 202,109 (42,878) 1.55 (1.36–1.77)6 1.50 (1.31–1.71)6 158,358 (29,776) 1.91 (1.61–2.26)6 1.77 (1.49–2.12)6
40–49 years 224,241 (31,804) 1.86 (1.65–2.11)6 1.78 (1.57–2.01)6 153,547 (19,337) 2.03 (1.73–2.39)6 1.82 (1.53–2.16)6
50–59 years 168,936 (20,957) 2.07 (1.78–2.41)6 1.97 (1.69–2.31)6 106,941 (13,582) 1.78 (1.51–2.11)6 1.69 (1.42–2.01)6
60–69 years 117,089 (14,077) 2.18 (1.79–2.65)6 2.00 (1.63–2.45)6 84,277 (11,235) 1.95 (1.65–2.30)6 1.76 (1.49–2.10)6
70–89 years 111,447 (12,268) 1.64 (1.35–1.99)6 1.55 (1.27–1.89)6 106,952 (13,757) 1.79 (1.58–2.03)6 1.69 (1.49–1.92)6
B. Hip fracture
Person-years (n1) Crude HR (95% CI) Adjusted HR3 (95% CI) Person-years (n1) Crude HR (95% CI) Adjusted HR2 (95% CI)
Age-group Males Females
0–29 years 263,584 (65,483) 2.01 (0.99–4.10) 1.90 (0.92–3.93) 218,777 (59,112) 4.71 (1.45–15.28)4 4.69 (1.44–15.23)4
30–39 years 211,666 (42,878) 3.42 (1.25–9.32)4 3.38 (1.24–9.25)4 162,501 (29,776) 5.63 (2.25–14.11)6 4.16 (1.52–11.43)5
40–49 years 234,658 (31,804) 3.59 (1.86–6.91)6 2.56 (1.24–5.29)4 158,903 (19,337) 4.55 (1.75–11.85)5 2.10 (0.65–6.78)
50–59 years 175,743 (20,957) 3.64 (2.07–6.41)6 3.23 (1.79–5.84)6 111,739 (13,582) 5.06 (2.80–9.14)6 4.38 (2.31–8.31)6
60–69 years 120,950 (14,077) 5.64 (3.55–8.97)6 5.21 (3.2–8.47)6 89,406 (11,235) 4.22 (2.73–6.56)6 3.21 (2.00–5.16)6
70–89 years 115,389 (12,268) 1.99 (1.43–2.78)6 1.71 (1.21–2.4)5 116,740 (13,757) 2.6 (2.13–3.18)6 2.34 (1.91–2.87)6

1Based on age at study entry.

2Adjusted for exposure to steroid medication, history of prior fracture, and presence of chronic kidney disease.

3Adjusted for exposure to steroid medication, history of prior fracture, presence of chronic kidney disease, and hypothyroidism.

4P < 0.05.

5P < 0.01.

6P < 0.001.